Paul Dominic B. Olinares

Paul Dominic B. Olinares

Auto-generated profile, based on publicly available information

Paul Dominic B. Olinares

Laboratory of Mass Spectrometry and Gaseous Ion Chemistry, The Rockefeller University, New York, NY 10065, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Cell
Verified
Journal Article
Closed access
JCJames Chen
James Chen
BMBrandon Malone
Brandon Malone
ELEliza Llewellyn
Eliza Llewellyn
MGMichael Grasso
Michael Grasso
PSPatrick M.M. Shelton
Patrick M.M. Shelton
ECElizabeth A. Campbell
Elizabeth A. Campbell

1 February 2023 in Nature
Verified
Journal Article
Closed access
PDF file
BMBrandon F. Malone
Brandon F. Malone
JPJason K. Perry
Jason K. Perry
POPaul Dominic B. Olinares
Paul Dominic B. Olinares
HLHery W. Lee
Hery W. Lee
JCJames Chen
James Chen
SDSeth A. Darst
Seth A. Darst

15 December 2021 in eLife
Verified
Journal Article
Open access
FMFred D Mast
Fred D Mast
PFPeter C Fridy
Peter C Fridy
NKNatalia E Ketaren
Natalia E Ketaren
JWJunjie Wang
Junjie Wang
EJErica Y Jacobs
Erica Y Jacobs
MRMichael P Rout
Michael P Rout
The emergence of SARS-CoV-2 variants threatens current vaccines and therapeutic antibodies and urgently demands powerful new therapeutics that can resist viral escape. We therefore generated a large nanobody repertoire to saturate the distinct and highly conserved available epitope space of SARS-CoV-2 spike, including the S1 receptor binding domain, N-terminal domain, and the S2 subunit, to identify new nanobody binding sites that may reflect novel mechanisms of viral neutralization. Structural mapping and functional assays show that indeed these highly stable monovalent nanobodies potently inhibit SARS-CoV-2 infection, display numerous neutralization mechanisms, are effective against emerging variants of concern, and are resistant to mutational escape. Rational combinations of these nanobodies that bind to distinct sites within and between spike subunits exhibit extraordinary synergy and suggest multiple tailored therapeutic and prophylactic strategies.

4 January 2021 in eLife
Verified
Journal Article
Open access
MSMarc A Schureck
Marc A Schureck
JDJoseph E Darling
Joseph E Darling
AMAlan Merk
Alan Merk
JSJinfeng Shao
Jinfeng Shao
GDGeervani Daggupati
Geervani Daggupati
Sanjay Arvind DesaiSanjay Arvind Desai
Sanjay Arvind Desai
Malaria parasites use the RhopH complex for erythrocyte invasion and channel-mediated nutrient uptake. As the member proteins are unique to Plasmodium spp., how they interact and traffic through subcellular sites to serve these essential functions is unknown. We show that RhopH is synthesized as a soluble complex of CLAG3, RhopH2, and RhopH3 with 1:1:1 stoichiometry. After transfer to a new host cell, the complex crosses a vacuolar membrane surrounding the intracellular parasite and becomes integral to the erythrocyte membrane through a PTEX translocon-dependent process. We present a 2.9 Å single-particle cryo-electron microscopy structure of the trafficking complex, revealing that CLAG3 interacts with the other subunits over large surface areas. This soluble complex is tightly assembled with extensive disulfide bonding and predicted transmembrane helices shielded. We propose a large protein complex stabilized for trafficking but poised for host membrane insertion through large-scale rearrangements, paralleling smaller two-state pore-forming proteins in other organisms.

22 January 2021 in eLife
Verified
Journal Article
Open access
JKJin Young Kang
Jin Young Kang
ELEliza Llewellyn
Eliza Llewellyn
JCJames Chen
James Chen
POPaul Dominic B Olinares
Paul Dominic B Olinares
JBJoshua Brewer
Joshua Brewer
SDSeth A Darst
Seth A Darst
Transcription-coupled repair (TCR) is a sub-pathway of nucleotide excision repair (NER) that preferentially removes lesions from the template-strand (t-strand) that stall RNA polymerase (RNAP) elongation complexes (ECs). Mfd mediates TCR in bacteria by removing the stalled RNAP concealing the lesion and recruiting Uvr(A)BC. We used cryo-electron microscopy to visualize Mfd engaging with a stalled EC and attempting to dislodge the RNAP. We visualized seven distinct Mfd-EC complexes in both ATP and ADP-bound states. The structures explain how Mfd is remodeled from its repressed conformation, how the UvrA-interacting surface of Mfd is hidden during most of the remodeling process to prevent premature engagement with the NER pathway, how Mfd alters the RNAP conformation to facilitate disassembly, and how Mfd forms a processive translocation complex after dislodging the RNAP. Our results reveal an elaborate mechanism for how Mfd kinetically discriminates paused from stalled ECs and disassembles stalled ECs to initiate TCR.

26 July 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JZJohn C. Zinder
John C. Zinder
POPaul Dominic B. Olinares
Paul Dominic B. Olinares
VSVladimir Svetlov
Vladimir Svetlov
MBMartin W. Bush
Martin W. Bush
ENEvgeny Nudler
Evgeny Nudler
TLTitia de Lange
Titia de Lange
Human shelterin is a six-subunit complex—composed of TRF1, TRF2, Rap1, TIN2, TPP1, and POT1—that binds telomeres, protects them from the DNA-damage response, and regulates the maintenance of telomeric DNA. Although high-resolution structures have been generated of the individual structured domains within shelterin, the architecture and stoichiometry of the full complex are currently unknown. Here, we report the purification of shelterin subcomplexes and reconstitution of the entire complex using full-length, recombinant subunits. By combining negative-stain electron microscopy (EM), cross-linking mass spectrometry (XLMS), AlphaFold modeling, mass photometry, and native mass spectrometry (MS), we obtain stoichiometries as well as domain-scale architectures of shelterin subcomplexes and determine that they feature extensive conformational heterogeneity. For POT1/TPP1 and POT1/TPP1/TIN2, we observe high variability in the positioning of the POT1 DNA-binding domain, the TPP1 oligonucleotide/oligosaccharide–binding (OB) fold, and the TIN2 TRFH domain with respect to the C-terminal domains of POT1. Truncation of unstructured linker regions in TIN2, TPP1, and POT1 did not reduce the conformational variability of the heterotrimer. Shelterin and TRF1-containing subcomplexes form fully dimeric stoichiometries, even in the absence of DNA substrates. Shelterin and its subcomplexes showed extensive conformational variability, regardless of the presence of DNA substrates. We conclude that shelterin adopts a multitude of conformations and argue that its unusual architectural variability is beneficial for its many functions at telomeres.